Table 2.
Characteristics of each cost-effectiveness analysis (CEA) for venous ulcers (n = 24)
| CEA (Original year of values) | Country (Original currency) | Perspective | Efficacy study design | Sample size | Population | Timeframe | Funding source a |
|---|---|---|---|---|---|---|---|
| Augustin 1999 (1989) [22] | Germany (DM) | Not reported | RCT | 25 | Mean 61 yrs; venous insufficiency | 24 wks | Not reported |
| DePalma 1999 (1998) [23] | USA (US$) | Not reported | RCT | 38 | Mean 61 yrs; venous insufficiency | max. 12 wks | Private |
| Glinski 1999 (1998) [24] | Poland (PLN) | Public payer | RCT | 140 | Mean 65 yrs; venous insufficiency | 24 wks | Not reported |
| Gordon 2006 (2005) [25] | Australia (AU$) | Society | RCT | 56 | Most >71 yrs; venous insufficiency | 24 wks | Not reported |
| Guest 2012 (2010) [26] | UK (£) | Public payer | Observational | 510 | Mean 80 yrs; venous insufficiency | 24 wks | Private |
| Iglesias 2006 (2004) [27] | UK (£) | Public payer | SR of RCTs | 434 | 66 yrs; venous insufficiency | 52 wks | Public |
| Iglesias 2004 (2001) [28] | UK (£) | Public payer | RCT | 387 | Mean 71 yrs; venous insufficiency | 52 wks | Public |
| Jull 2008 (2005) [29] | New Zealand (NZ$) | Public payer | RCT | 368 | Mean 68 yrs; venous insufficiency | 12 wks | Mixed |
| Junger 2008 (2007) [30] | Germany (DM) | Not reported | RCT | 39 | Mean 67 yrs; venous insufficiency | 17 wks | Private |
| Kerstein 2000 (1995) [31] | USA (US$) | Not reported | Observational | 81 | Mean 65 yrs; venous insufficiency | 3 yrs | Not reported |
| Kikta 1988 (1987) [32] | USA (US$) | Not reported | RCT | 87 | Venous insufficiency; (ages NR) | 24 wks | Not reported |
| Michaels 2009 (2007) [33] | UK(£) | Public payer | RCT | 213 | Mean 71 yrs; venous insufficiency | 12 wks | Public |
| Morrell 1998 (1995) [34] | UK (£) | Public payer | RCT | 233 | Mean 74 yrs; venous insufficiency | 52 wks | Public |
| O’Brien 2003 (2000) [35] | Ireland (€) | Public payer | RCT | 200 | Mean 72 yrs; venous insufficiency | 12 wks | Private |
| Oien 2001 (1997) [36] | Sweden (£) | Not reported | Observational | 68 | Mean 76 yrs; venous insufficiency | 12 wks | Not reported |
| Sibbald 2001 (1997) [37] | Canada (CAN$) | Society | RCT | 293 | Elderly; venous insufficiency | 13 wks | Private |
| Taylor 1998 (1987) [38] | UK (£) | Not reported | RCT | 36 | Mean 75 yrs; venous insufficiency | 12 wks | Private |
| Ukat 2003 (2002) [39] | Germany (€) | Not reported | RCT | 89 | Mean 69 yrs; venous insufficiency | 12 wks | Private |
| Watson 2011 (2007) [40] | UK (£) | Public payer | RCT | 337 | Mean 69 yrs; venous insufficiency | 52 wks | Public |
| Pham 2012 (2009) [41] | Canada (CAN$) | Society | RCT | 424 | Mean 65 yrs; venous insufficiency; most fully mobile | max. 52 wks | Public |
| Schonfeld 2000 (1996) [42] | USA(US$) | Public payer | RCT | 240 | Mean 60 yrs; venous insufficiency | 52 wks | Private |
| Simon 1996 (1993) [43] | UK (£) | Not reported | Observational | 901 | Venous insufficiency; (ages not reported) | 13 wks | Mixed |
| Carr 1999 (1998) [44] | UK (£) | Public payer | RCT | 233 | Mean 73 yrs; venous insufficiency | 52 wks | Private |
| Guest 2009 (2007) [45] | UK (£) | Public payer | RCT | 83 | Mean 71 yrs; venous insufficiency | 52 wks | Private |
RCT, Randomized clinical trial; SR, Systematic review; wks, Weeks; yrs, Years.
aMixed here indicates both private and public funding.